![Vibegron [Gemtesa] – (Beta-3 Adrenergic Agonist)](data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%200%200'%3E%3C/svg%3E)
Introduction
Vibegron, sold under the trade name Gemtesa, is a beta-3 adrenergic agonist used to treat overactive bladder (OAB). Like Mirabegron, it relaxes the bladder muscles, providing symptom relief without the common side effects associated with antimuscarinics.
Purpose
- Reduces urinary urgency, frequency, and urge incontinence in patients with OAB.
- Increases bladder capacity and reduces involuntary muscle contractions.
How It Works
Vibegron activates beta-3 adrenergic receptors in the bladder, relaxing the detrusor muscle and increasing bladder storage capacity, resulting in fewer symptoms of urgency and frequency.
Usage
- Taken as an oral tablet, typically once daily, with or without food.
- Consistent use is required for optimal symptom relief, with effects noticeable within a few weeks.
Considerations
- Common side effects include headache, urinary tract infection, and diarrhea.
- Does not typically affect blood pressure, making it a safer choice for patients with hypertension.
- Generally well-tolerated, with minimal interactions reported.
At Crossroads Urology
At Crossroads Urology, Vibegron is an excellent alternative for patients seeking effective OAB symptom control with fewer side effects. Our providers carefully assess each patient’s needs to determine the best treatment approach.
Conclusion
Vibegron [Gemtesa] is a highly effective treatment for overactive bladder, offering relief and improved quality of life. Contact Crossroads Urology today to learn more about this medication and how it can benefit you.
